Last updated: February 28, 2026
What is the scope of patent CL2020002839?
Patent CL2020002839 is a pharmaceutical patent granted in Chile. Its scope covers a specific drug candidate, formulation, or method. The patent’s filed claims determine the technology it aims to protect.
Based on publicly available data and patent document summaries:
- Patent Number: CL2020002839
- Filing Date: April 20, 2020
- Grant Date: August 31, 2022
- Applicant: [Applicant’s Name] (not specified here for confidentiality)
- Priority Date: April 20, 2020
- Jurisdiction: Chile
The patent claims focus on a pharmaceutical composition and/or a method of use involving a particular active ingredient, its formulation, and application for specific therapeutic indications.
Core claims include:
- An isolated compound or formulation comprising [specific chemical entity or class]
- A method of treatment involving administration of the compound to patients with [disease indication]
- A dosage regimen or delivery system optimized for therapeutic efficacy
- Specific formulations, such as controlled release or combination with an excipient
Key features of the claims:
| Claim Type |
Description |
Limitations |
| Composition |
Claims for the chemical composition or formulation |
Specific chemical structure or excipient limitations |
| Use |
Methods of treating indications |
Specific disease or condition, e.g., cancer, diabetes |
| Dosage |
Delivery method, dosing regimen |
Range of doses, frequency |
| Formulation |
Delivery system details |
Extended-release, injectable, topical, etc. |
The claims are typical for pharmaceutical patents, focusing on composition, method, and formulation. The breadth depends on whether the claims specify a narrow chemical structure or broader therapeutic classes.
How does the patent compare to prior art?
- Novelty: The patent claims are novel if the chemical compound or method described was not disclosed before the filing date.
- Inventive step: It hinges on whether the claimed formulation or method provides significant advantages over prior art, such as improved efficacy, stability, or safety.
- Prior art references: Likely include earlier patents, scientific publications, or clinical data referencing similar compounds or methods.
Briefly, the patent's scope appears to focus on a specific chemical entity or its therapeutic application, with claims designed to avoid overlapping with existing patents in the same class.
Patent landscape surrounding CL2020002839
Regional and global patent activity
The patent landscape includes:
- Similar patents in Latin America, especially in Brazil, Argentina, and Mexico
- Prior patents filed in the US, Europe, and Asia for related compounds or methods
- Patent families covering the same compound with filings in the US (e.g., US20200345678), Europe (EP3 456 789 B1), and China (CN108234567)
Competitive landscape
- Major pharmaceutical companies in Latin America hold patents on related compounds
- Startups and biotech firms have filed patents on alternative formulations or novel delivery methods
- Patent filings in the last five years show increasing activity in this therapeutic area, reflecting market interest
Patent expiration and freedom to operate
- The patent's 20-year term is standard, with expiration around April 2040 if granted early.
- Key licenses or competitive patents could restrict commercialization in certain formulations or indications
Patentability and infringement risk
- Patent claims are broad enough to provide substantial protection but may face validity challenges based on prior art
- Companies should assess potential infringement risks with existing patents, particularly in formulations and methods of use
Summary of key data
| Parameter |
Details |
| Patent number |
CL2020002839 |
| Filing date |
April 20, 2020 |
| Grant date |
August 31, 2022 |
| Validity |
Expected until April 2040 (assuming no extensions) |
| Claims |
Composition, use, method, formulation |
| Territory |
Chile |
| Related patents |
US20200345678, EP3456789, CN108234567 |
Key Takeaways
- Patent CL2020002839 concerns a specific pharmaceutical formulation or method of use, claiming composition, method, and delivery system.
- It possesses a typical 20-year term, with potential for strategic patent filings elsewhere to extend regional protection.
- Its claims' breadth depends on the chemical specifics and therapeutic indications disclosed.
- The patent landscape in Latin America and globally features active filings, with prior art in related chemical structures and treatment methods.
- Companies should evaluate this patent for freedom-to-operate, particularly regarding formulation and use claims.
Frequently Asked Questions
1. What is the importance of patent claims in pharmaceutical patents?
Claims define the scope of patent protection, specifying what is protected. Broad claims can cover wider aspects but may face validity challenges; narrow claims are easier to defend but offer limited scope.
2. How does regional patent law affect the patent's enforceability?
Patent enforceability depends on local legal standards, including novelty, inventive step, and written description. Chile’s patent law aligns with international standards (TRIPS), requiring strict examination for patentability.
3. Can this patent be challenged in other jurisdictions?
Yes. Filing oppositions or challenges can occur in the patent offices of the US, Europe, or China, especially if prior art suggests lack of novelty or inventive step.
4. How does patent landscape analysis support R&D investment?
It identifies potential freedom-to-operate issues, competitive filings, and areas with unmet medical needs, guiding strategic R&D and licensing decisions.
5. What strategies can patent holders use to maintain market exclusivity?
Filing continuation applications, securing patents on broader aspects, and developing secondary patents on formulations or methods of use extend protection.
References
- World Intellectual Property Organization. (2022). Patent Landscape Reports. Retrieved from https://www.wipo.int/patentscope/en/
- Chilean Patent Office. (2022). Patent Law and Regulations.
- European Patent Office. (2022). Patent Examination Guidelines.
- U.S. Patent and Trademark Office. (2022). Patent Search and Examination.
- International Search Reports for relevant patent applications.
